Brian D. Lehmann
Impact in
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Oncology top 0.2%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Breast Cancer Treatment Studies 18
- Cancer Genomics and Diagnostics 16
- Oncology 40
- Cancer-related Molecular Pathways 11
- Cancer Cells and Metastasis 8
- HER2/EGFR in Cancer Research 8
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Jennifer A. PietenpolYu ShyrMelinda E. SandersXi ChenJoshua A. BauerA. Bapsi ChakravarthyJames A. McCubreyDavid M. Terrian
- Journals
- Cancer Research (8 papers)Clinical Cancer Research (6 papers)Breast Cancer Research (4 papers)Journal of Clinical Oncology (4 papers)Cell Cycle (4 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Brian D. Lehmann
68 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Cancer Research 4.4k
- Oncology 5.7k
- Molecular Biology 5.7k
- Pulmonary and Respiratory Medicine 2.1k
- Pathology and Forensic Medicine 960
Countries citing papers authored by Brian D. Lehmann
This map shows the geographic impact of Brian D. Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian D. Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian D. Lehmann more than expected).
Fields of papers citing papers by Brian D. Lehmann
This network shows the impact of papers produced by Brian D. Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian D. Lehmann. The network helps show where Brian D. Lehmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian D. Lehmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 18 | |
| 5 | 2023 | 31 | |
| 6 | 2021 | 19 | |
| 7 | 2020 | 10 | |
| 8 | 2019 | 11 | |
| 9 | 2019 | 113 | |
| 10 | 2017 | 15 | |
| 11 | Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection Hit paper breakdown → | 2016 | 946 |
| 12 | 2015 | 89 | |
| 13 | 2014 | 229 | |
| 14 | 2014 | 96 | |
| 15 | 2014 | 2 | |
| 16 | 2013 | 127 | |
| 17 | 2013 | 124 | |
| 18 | Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes Hit paper breakdown → | 2013 | 525 |
| 19 | 2013 | 40 | |
| 20 | 2008 | 15 |
About Brian D. Lehmann
Brian D. Lehmann is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Biophysics, having authored 71 papers that have together received 11.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (18 papers), Cancer Genomics and Diagnostics (16 papers), Advanced Breast Cancer Therapies (13 papers), Cancer-related Molecular Pathways (11 papers), Cancer Cells and Metastasis (8 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Genomics and Phylogenetic Studies (5 papers). The work is most often cited by research in Cancer Research (4.4k citations), Oncology (5.7k citations), Molecular Biology (5.7k citations), Pulmonary and Respiratory Medicine (2.1k citations) and Pathology and Forensic Medicine (960 citations). Brian D. Lehmann has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Jennifer A. Pietenpol, Yu Shyr, Melinda E. Sanders, Xi Chen, Joshua A. Bauer, A. Bapsi Chakravarthy, James A. McCubrey, David M. Terrian, William H. Chappell and Linda S. Steelman. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Breast Cancer Research, Journal of Clinical Oncology and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.